Belzutifan versus Everolimus in Advanced Kidney Cancer: A Commentary on LITESPARK-005 Trial from ESMO 2023.
- Published in:
- Kidney Cancer (2468-4562), 2024, v. 8, n. 1, p. 23, doi. 10.3233/KCA-230024
- By:
- Publication type:
- Article
Works matching IS 24684562 AND DT 2024 AND VI 8 AND IP 1
Results: 3
1
2
Efficacy, Effectiveness, and Safety of Interventions for Von Hippel-Lindau Associated Renal Cell Carcinoma: A Systematic Literature Review.
- Published in:
- Kidney Cancer (2468-4562), 2024, v. 8, n. 1, p. 1, doi. 10.3233/KCA-230021
- By:
- Publication type:
- Article
3
Adjuvant Therapy in Renal Cell Cancer.
- Published in:
- Kidney Cancer (2468-4562), 2024, v. 8, n. 1, p. 17, doi. 10.3233/KCA-230013
- By:
- Publication type:
- Article